BioLargo, Inc.
BLGO
$0.219
-$0.0027-1.22%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -170.29% | -181.71% | -39.09% | 55.25% | 66.79% |
| Total Depreciation and Amortization | 2.53% | 107.32% | -23.86% | -10.53% | -8.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -107.88% | -125.10% | -76.57% | -140.90% | 70.59% |
| Change in Net Operating Assets | -12,975.00% | -222.34% | -313.24% | -373.13% | 102.22% |
| Cash from Operations | -1,302.65% | -480.46% | -95,700.00% | -93.78% | 89.82% |
| Capital Expenditure | -- | -- | 117.12% | 80.98% | -353.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 153.63% | -- | 60.96% | 80.98% | -353.16% |
| Total Debt Issued | -- | -- | 1,229.23% | -- | -- |
| Total Debt Repaid | -66.67% | 20.00% | -103.64% | 66.67% | 40.00% |
| Issuance of Common Stock | 109.78% | -72.89% | -- | 232.47% | 21.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 5,628.57% | -- | -- |
| Cash from Financing | 183.58% | -20.04% | 109.20% | 50.69% | -46.89% |
| Foreign Exchange rate Adjustments | 100.00% | -120.83% | 140.52% | 1,100.00% | -771.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 111.42% | -223.46% | -167.20% | -65.67% | 37.94% |